期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

弥漫大B细胞淋巴瘤治疗的临床研究进展 被引量：5

原文传递
导出
摘要 弥漫大B细胞淋巴瘤（DLBCL）是最常见的侵袭性非霍奇金淋巴瘤（NHL）,R-CHOP方案（利妥昔单抗加环磷酰胺加柔红霉素加长春新碱加泼尼松）的应用已逐渐使DLBCL转变为潜在可治愈性疾病,但仍有部分患者对其不敏感,难以达到完全缓解（CR）或缓解后又复发。
作者 杨宁宁 王欣
机构地区 山东省立医院血液科
出处 《临床血液学杂志》 CAS 2012年第6期753-756,共4页 Journal of Clinical Hematology
基金 山东省科技发展计划项目(No:2010GSF10250 2007GG10) 山东省自然科学基金(No:2009ZRB14176 Y2007C053)
关键词 B细胞淋巴瘤 治疗 临床研究
分类号 R733.4 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1MORSCHHAUSER F, LEONARD J P, FAYAD L, etal. Humanized anti-CD20 antibody?veltuzumab, in refrac-tory/ recurrent non-Hodgkin,s lymphoma: phase T/II re-sults[J]. J Clin Oncol,2009,27 :3346-3353.
  • 2MICAILEF I N,MAURER M J, WISEMAN G,et al_Epratuzumab with rituximab, cyclophosphamide, doxoru-bicin, vincristine, and prednisone chemotherapy ( ER-CH()P)in patients with previously untreated diffuse largeB-cell lymphoma[J]. Blood?2011,118:4053 —4061.
  • 3ADVANI R, FOREROTORRES A,FURMAN R R,etal. Phase I study of the humanized anti-CD40 monoclonalantibody dacetuzumab in refractory or recurrent non-Hodgkin^ lymphoma[J]. J Clin Oncol,2009,27 : 4371 —4377.
  • 4LOZANSKI G,HEEREMA N’FLINN I,et al. Alemtu-zumab is an effective therapy for chronic lymphocyticleukemia with p53 mutations and deletions [J]. Blood,2004,103:3278—3281.
  • 5STOPECK A T, UNGER J M,RIMSZA L M,et al. Aphase n trial of single agent bevacizumab in patients withrelapsed, aggressive non-Hodgkin lymphoma: Southwestoncology group study S0108[J]. Leuk Lymphoma,2009,50:728 — 735.
  • 6HURWITZ H,FEHRENBACHER L, NOVOTNY W,et al. Bevaciz mab plus irinotecan, fluorouracil, and leuco-vorin for metastatic colorectal cancer[J]. N Engl J Med,2004,350:2335 — 2342.
  • 7GERBER H P,FERRARA N. Pharmacology and phar-macodynamics of bevacizumab as monotherapy or in com-bination with cytotoxic therapy in preclinical studies[J].Cancer Res, 2005,65 : 671 — 680.
  • 8GANJCO K N,AN C S,ROBERTSON MJ,et al. Ritux-imab,bevacizumab and CHOP ( RA-CHOP) in untreateddiffuse large B-cell lymphoma: safety, biomarker, andpharmacokinetic analysis[J]. Leuk Lymphoma, 2006?47 :998-1005.
  • 9WIERNIK P H,LOSS()S I S’TUSCANO J M,et al. Le-nalidomide monotherapy in relapsed or refractory aggres-sive non-Hodgkin ^ s lymphoma [J]. J Clin Oncol,2008,26:4952-4957.
  • 10WITZIG T E, VOSE J M,ZINZANI P L,et al. An inter-national phase If trial of single-agent lenalidomide for re-lapsed or refractory aggressive B-Cell non-Hodgkin lym-phoma[J]. Ann Oncol,2011,22 : 1622 —1627.

同被引文献39

  • 1徐万峰,胡成利,徐希见,秦风香.膀胱异位嗜铬细胞瘤一例[J].临床放射学杂志,2005,24(1):45-45. 被引量：3
  • 2刘晓明,潘光耀,钱君.原发性膀胱神经内分泌癌2例[J].现代泌尿外科杂志,2005,10(5):301-301. 被引量：3
  • 3邹宏志,吴惠娟,谢新生,陈胜梅.67例原发性结外非霍奇金淋巴瘤早期误诊分析及首发症状回顾[J].肿瘤基础与临床,2006,19(3):225-227. 被引量：2
  • 4关勇（综述）,卢振霞（审校）.弥漫大B细胞淋巴瘤异质性研究进展[J].国际肿瘤学杂志,2007,34(4):305-308. 被引量：1
  • 5Witzig TE, VoseJM, Zinzanni PL, et al. An international phase II trial of single-agent lenalidomide for relapsed or refractory ad- dressive B-Cell qon-Hodgkin lymphoma[J]. Ann Oncol, 2011, 22 (7):1622-1627.
  • 6Rural J, Martin P, Furman RR, et al. Bortezomib plus CHOP-ritux- imab for previouslyuntreated diffuselarge B-cell lymphoma and mantle cell lymphoma[J].J Clin Oncol,2011,29(6):690-697.
  • 7Dreyling M, Thieblemont C, Gallamini A, et al. ESMO Consen- sus conferences: guidelines on malignant lymphoma. Part 2 : mar- ginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma[ J]. Ann Oncol, 2013, 24(4) :857-877.
  • 8Kagami Y, Itoh K, Tobinai K, et al. Phase II study of cyclophospha- mide, doxorubicin, vincristine, prednisolone(CHOP) therapy for new- ly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin' s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508[J]. Int J Hematol, 2012, 96(1 ) :74-83.
  • 9Tsai PC, Hemandez-Ilizaliturfi FJ, Bangja N, et al. Regulation of CD20 in rituximab- resistant cell lines and B-cell non-Hodgkin lym- phoma[J]. Clin Cancer Res, 2012, 18(4) : 1039-1050 .
  • 10Tomita N, Takasaki H, Miyashita K, et al. R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma [ J ]. Br J Haematol, 2013, 161(3) :383-388.

引证文献5

二级引证文献9

临床血液学杂志
2012年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部